Top Story

Vision-threatening abnormalities possible in infants with presumed Zika virus-associated microcephaly

February 10, 2016

Infants who are born with microcephaly due to congenital infection from presumed exposure to the Zika virus may have vision-threatening abnormalities, according to a study.

The case series included 29 infants with microcephaly and a presumed diagnosis of congenital Zika virus infection. Ophthalmologists who specialized in medical/surgical retina, uveitis and neuro-ophthalmology evaluated the infants and their mothers in December 2015 at the Roberto Santos General Hospital in Salvador, Brazil.

Meeting News Coverage

Anti-VEGF with targeted retinal photocoagulation does not reduce treatment burden for DME patients

February 10, 2016
MIAMI — Anti-VEGF injections in combination with targeted retinal photocoagulation did not show a decrease in treatment burden in patients with diabetic macular…
Breaking News

TearLab withdraws proposed public offering of common stock

February 10, 2016
TearLab has withdrawn its proposed public offering of common stock, according to a company press release. Due to current market conditions, the company believes that it…

BLOG: Three reasons why Medicare is our best payer

February 10, 2016
The cover story in this issue of Ocular Surgery News addresses the phenomenon of physicians opting out of Medicare. While few in our profession have made this switch…
Meeting News Coverage

Speaker: Venture capital drives innovation in medical retina research

February 9, 2016
MIAMI — Robust investment by venture capitalists is making up for stagnant government funding for medical research, particularly in the ophthalmic and…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »

Avoiding “Loss of Chance”… Improving the Screening, Treatment, and Referral of Patients with Diabetic Retinopathy

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Meeting News CoverageVideo

VIDEO: Surgeon anticipates FDA approval of collagen cross-linking for treatment of keratoconus, ectasia

February 2, 2016
More »